These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8129779)

  • 1. Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis.
    Esser RE; Angelo RA; Murphey MD; Watts LM; Thornburg LP; Palmer JT; Talhouk JW; Smith RE
    Arthritis Rheum; 1994 Feb; 37(2):236-47. PubMed ID: 8129779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis.
    Esser RE; Watts LM; Angelo RA; Thornburg LP; Prior JJ; Palmer JT
    J Rheumatol; 1993 Jul; 20(7):1176-83. PubMed ID: 8371213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of daily compared to intermittent administration of IL-1Ra for protection against bone and cartilage destruction in collagen-challenged mice.
    Inoue K; Masuko-Hongo K; Okamoto M; Nishioka K
    Clin Exp Rheumatol; 2003; 21(1):33-9. PubMed ID: 12673887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effect of N-(benzyloxycarbonyl)-L-phenylalanyl-L-tyrosinal on bone resorption in vitro and in vivo.
    Woo JT; Yamaguchi K; Hayama T; Kobori T; Sigeizumi S; Sugimoto K; Kondo K; Tsuji T; Ohba Y; Tagami K; Sumitani K
    Eur J Pharmacol; 1996 Apr; 300(1-2):131-5. PubMed ID: 8741178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
    Sondergaard BC; Henriksen K; Wulf H; Oestergaard S; Schurigt U; Bräuer R; Danielsen I; Christiansen C; Qvist P; Karsdal MA
    Osteoarthritis Cartilage; 2006 Aug; 14(8):738-48. PubMed ID: 16563811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cartilage degradation in rat collagen-induced arthritis but not adjuvant arthritis by the neutrophil elastase inhibitor MDL 101,146.
    Janusz MJ; Durham SL
    Inflamm Res; 1997 Dec; 46(12):503-8. PubMed ID: 9459081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice.
    Svelander L; Erlandsson-Harris H; Astner L; Grabowska U; Klareskog L; Lindstrom E; Hewitt E
    Eur J Pharmacol; 2009 Jun; 613(1-3):155-62. PubMed ID: 19358841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPDPLQ
    Löfvall H; Katri A; Dąbrowska A; Karsdal MA; Luo Y; He Y; Manon-Jensen T; Dziegiel MH; Bay-Jensen AC; Thudium CS; Henriksen K
    Sci Rep; 2019 Feb; 9(1):3050. PubMed ID: 30816326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidyl fluoromethyl ketones as inhibitors of cathepsin B. Implication for treatment of rheumatoid arthritis.
    Ahmed NK; Martin LA; Watts LM; Palmer J; Thornburg L; Prior J; Esser RE
    Biochem Pharmacol; 1992 Sep; 44(6):1201-7. PubMed ID: 1417942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine protease activity is up-regulated in inflamed ankle joints of rats with adjuvant-induced arthritis and decreases with in vivo administration of a vinyl sulfone cysteine protease inhibitor.
    Biroc SL; Gay S; Hummel K; Magill C; Palmer JT; Spencer DR; Sa S; Klaus JL; Michel BA; Rasnick D; Gay RE
    Arthritis Rheum; 2001 Mar; 44(3):703-11. PubMed ID: 11263786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice.
    Shen X; Li C; Zhao H; Li S; Chen J; Kobayashi Y; Shen W
    J Ethnopharmacol; 2011 Mar; 134(2):399-405. PubMed ID: 21215307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WF14861, a new cathepsins B and L inhibitor produced by Colletotrichum sp. II. Biological properties.
    Otsuka T; Muramatsu Y; Niikura K; Okamoto M; Hino M; Hashimoto S
    J Antibiot (Tokyo); 1999 Jun; 52(6):542-7. PubMed ID: 10470678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation.
    Hayer S; Bauer G; Willburger M; Sinn K; Alasti F; Plasenzotti R; Shvets T; Niederreiter B; Aschauer C; Steiner G; Podesser BK; Smolen JS; Redlich K
    Dis Model Mech; 2016 Nov; 9(11):1329-1338. PubMed ID: 27638666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.
    Augello A; Tasso R; Negrini SM; Cancedda R; Pennesi G
    Arthritis Rheum; 2007 Apr; 56(4):1175-86. PubMed ID: 17393437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.
    Conway JG; Wakefield JA; Brown RH; Marron BE; Sekut L; Stimpson SA; McElroy A; Menius JA; Jeffreys JJ; Clark RL
    J Exp Med; 1995 Aug; 182(2):449-57. PubMed ID: 7629505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
    Ishikawa T; Nishigaki F; Christgau S; Noto T; Mo J; From N; Minoura K; Hirayama Y; Ohkubo Y; Mutoh S
    J Rheumatol; 2004 Jun; 31(6):1174-9. PubMed ID: 15170932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor.
    Podolin PL; Bolognese BJ; Carpenter DC; Davis TG; Johanson RA; Fox JH; Long E; Dong X; Marquis RW; Locastro SM; Terfloth GJ; Kurali E; Peterson JJ; Smith BR; McQueney MS; Yamashita DS; Capper-Spudich EA
    J Immunol; 2008 Jun; 180(12):7989-8003. PubMed ID: 18523262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
    Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
    J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.